Magnetar Financial’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-655,522
Closed -$6.73M – 670
2023
Q2
$6.73M Sell
655,522
-258,217
-28% -$2.64M 0.15% 108
2023
Q1
$9.25M Sell
913,739
-22,262
-2% -$224K 0.18% 111
2022
Q4
$9.34M Hold
936,001
– – 0.16% 159
2022
Q3
$9.11M Sell
936,001
-56,889
-6% -$553K 0.13% 201
2022
Q2
$9.6M Buy
992,890
+1,584
+0.2% +$15.4K 0.1% 191
2022
Q1
$9.7M Sell
991,306
-5,707
-0.6% -$55.1K 0.1% 201
2021
Q4
$9.8M Buy
997,013
+66,966
+7% +$656K 0.1% 221
2021
Q3
$9.14M Buy
+930,047
New +$9.19M 0.09% 228

Magnetar Financial's DALS Position: Q3 2023 in Review

Magnetar Financial sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 655,522 shares — an estimated $6.73M sold.

Magnetar Financial first reported a position in DALS in Q3 2021 and held it in 8 quarters. The position peaked at $9.8M in Q4 2021. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Magnetar Financial reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Magnetar Financial sold 655,522 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $6.73M.
  • Magnetar Financial first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 8 quarters.
  • Magnetar Financial's DA32 Life Science Tech Acquisition Corp position peaked at $9.8M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on Magnetar Financial's 13F filing for Q3 2023, filed 14 Nov 2023.